S
Sensei Biotherapeutics D
D
SNSE
6.68000
USD
6.34
(1,864.71%)
مغلق
حجم التداول
351
الربح لكل سهم
-26
العائد الربحي
-
P/E
-0
حجم السوق
168,389,894
العنوان: Sensei Biotherapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).